- Clinical Trials
- February 2024
- 60 Pages
Global
From €1445EUR$1,500USD£1,242GBP
- Report
- January 2024
- 206 Pages
Global
From €3499EUR$3,633USD£3,009GBP
€4998EUR$5,190USD£4,298GBP
- Report
- June 2023
- 110 Pages
Global
From €5730EUR$5,950USD£4,928GBP
- Report
- February 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 189 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- September 2023
- 166 Pages
Global
From €2408EUR$2,500USD£2,071GBP
- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- July 2022
- 100 Pages
Global
From €2648EUR$2,750USD£2,278GBP
- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- January 2022
- 60 Pages
Global
From €3804EUR$3,950USD£3,271GBP
- Report
- January 2022
- 200 Pages
Global
From €7223EUR$7,500USD£6,212GBP
- Report
- January 2022
- 200 Pages
Global
From €7223EUR$7,500USD£6,212GBP
- Report
- January 2022
- 200 Pages
Global
From €7223EUR$7,500USD£6,212GBP
- Report
- January 2022
- 200 Pages
Global
From €7223EUR$7,500USD£6,212GBP
- Report
- May 2022
- 46 Pages
Global
From €1926EUR$2,000USD£1,656GBP
- Report
- April 2023
- 147 Pages
Global
From €5777EUR$5,999USD£4,968GBP
Myopia Drug is a type of Optical Disorders Drug used to treat nearsightedness, or myopia. Myopia is a condition in which the eye is unable to focus on distant objects, resulting in blurred vision. Myopia Drugs are designed to reduce the progression of myopia by slowing the elongation of the eye. These drugs are typically administered as eye drops or injections, and may be used in combination with other treatments such as eyeglasses or contact lenses.
Myopia Drugs are becoming increasingly popular as a treatment option for myopia, as they offer a non-invasive and reversible solution. They are also seen as a more cost-effective option than other treatments such as laser surgery.
Some companies in the Myopia Drug market include Allergan, Santen Pharmaceuticals, Bausch + Lomb, and Shire. Show Less Read more
